William D. Waddill, Director: Arrowhead Pharmaceuticals ARWR Sell · Filed 24/12/18

Trade details

Type: Insider sale
Amount: $82,583.88
Shares · price: 3,747 sh · $22.04 a share
Held after: 40,378 sh
Stock: Arrowhead Pharmaceuticals ARWR
Person: William D. WaddillDirector
Trade date: 24/12/17
Filed: 24/12/18
Days to filing: 1 days

Sold 8.5% of holdings

Share of holding sold: 8.5%

Arrowhead Pharmaceuticals trades, last 26 weeks

What else happened in Arrowhead Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/11/17~25/01/16

William D. Waddill's recent trades

William D. WaddillDirector
Sell10b5-1 planProtagonist Therapeutics
Sell10b5-1 plan
Protagonist Therapeutics
PTGX
$1.1M
9,000 sh
$1.1M
Filed 06/25
Traded 06/23
William D. WaddillDirector
Planned sale10b5-1 planProtagonist Therapeutics
Planned sale10b5-1 plan
Protagonist Therapeutics
PTGX
$1M
9,000 sh
$1M
Filed 06/23
Traded 06/23
William D. WaddillDirector
Sell10b5-1 planProtagonist Therapeutics
Sell10b5-1 plan
Protagonist Therapeutics
PTGX
$969.1K
9,000 sh
$969.1K
Filed 06/11
Traded 06/10
William D. WaddillDirector
Planned sale10b5-1 planProtagonist Therapeutics
Planned sale10b5-1 plan
Protagonist Therapeutics
PTGX
$952.8K
9,000 sh
$952.8K
Filed 06/10
Traded 06/10
William D. WaddillDirector
Sell10b5-1 planProtagonist Therapeutics
Sell10b5-1 plan
Protagonist Therapeutics
PTGX
$896.8K
9,000 sh
$896.8K
Filed 06/01
Traded 05/29

William D. Waddill, Director — sold $82.6K of Arrowhead Pharmaceuticals ARWR · 8.5% of holdings · 10b5-1 plan | Whalegun